Market Value3,273,687,000
Total Holdings87
File Date2022-05-16
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
CANO / Cano Health, Inc.
TPR / Tapestry, Inc.
SQ / Block, Inc.
XOP / SPDR Series Trust - SPDR S&P Oil & Gas Exploration & Production ETF
ETSY / Etsy, Inc.
HRTX / Heron Therapeutics, Inc.
ADI / Analog Devices, Inc.
PNT / POINT Biopharma Global Inc.
RPRX / Royalty Pharma plc
ABCL / AbCellera Biologics Inc. Call
IOVA / Iovance Biotherapeutics, Inc.
CMRX / Chimerix, Inc.
MGTX / MeiraGTx Holdings plc
OMEG / Omega Alpha SPAC - Class A
DECK / Deckers Outdoor Corporation
EUROPEAN BIOTECH ACQUTN CORP / *W EXP 03/06/202 (G3167F128)
RIVN / Rivian Automotive, Inc.
KYG9127T1242 / WARRANTS
VGG3141W1225 / Eucrates Biomedical Acquisition Corp.
CANO.WS / Cano Health, Inc. Redeemable Warrants, each whole warrant exercisable for one Class A a
US6710052050 / OPY Acquisition Corp. I
FRAZIER LIFESCIENCES ACQU CO / *W EXP 11/30/202 (G3710A113)
DICE / DICE Therapeutics Inc
CHRS / Coherus Oncology, Inc.
WRBY / Warby Parker Inc.
GRAB / Grab Holdings Limited
ALIT / Alight, Inc.
CPRT / Copart, Inc.
CVNA / Carvana Co.
MIST / Milestone Pharmaceuticals Inc.
US31809Y1111 / FINSERV ACQUISITION CORP II WT EXPIRATION: 02/03/26
KZR / Kezar Life Sciences, Inc.
DBTX / Decibel Therapeutics Inc
MRNS / Marinus Pharmaceuticals, Inc.
KBR / KBR, Inc.
MRTX / Mirati Therapeutics, Inc.
BBWI / Bath & Body Works, Inc.
NUVL / Nuvalent, Inc.
V / Visa Inc.
MAR / Marriott International, Inc.
FLAC / Frazier Lifesciences Acquisition Corp - Class A
ADBE / Adobe Inc.
AUPH / Aurinia Pharmaceuticals Inc.
SLDB / Solid Biosciences Inc.
SIOX / Sio Gene Therapies Inc.
ROIV / Roivant Sciences Ltd.
TRDA / Entrada Therapeutics, Inc.
IMRX / Immuneering Corporation
TMPM / Turmeric Acquisition Corp - Class A
RACB / Research Alliance Corp II - Class A
BLSA / BCLS Acquisition Corp - Class A
MNST / Monster Beverage Corporation
ORIC / ORIC Pharmaceuticals, Inc.
ARNA / Arena Pharmaceuticals Inc
JNJ / Johnson & Johnson
IQV / IQVIA Holdings Inc.
INZY / Inozyme Pharma, Inc.
PWR / Quanta Services, Inc.
TEL / TE Connectivity plc
AMZN / Amazon.com, Inc.
MA / Mastercard Incorporated
CNC / Centene Corporation
SRNE / Sorrento Therapeutics, Inc.
XLE / The Select Sector SPDR Trust - The Energy Select Sector SPDR Fund
SPGI / S&P Global Inc.
OPEN / Opendoor Technologies Inc.
EBAC / European Biotech Acquisition Corp - Class A
RH / RH
PHVS / Pharvaris N.V.
MQ / Marqeta, Inc.
EUCR / Eucrates Biomedical Acquisition Corp
UNP / Union Pacific Corporation
AMAM / Ambrx Biopharma Inc.
SCHW / The Charles Schwab Corporation
XENE / Xenon Pharmaceuticals Inc.
TERN / Terns Pharmaceuticals, Inc.
ALLO / Allogene Therapeutics, Inc.
NTRA / Natera, Inc.
WYNN / Wynn Resorts, Limited
AGIO / Agios Pharmaceuticals, Inc.
GMTX / Gemini Therapeutics Inc
KDNY / Chinook Therapeutics Inc
OTIC / Otonomy Inc
TMO / Thermo Fisher Scientific Inc.
LVS / Las Vegas Sands Corp.
BNTC / Benitec Biopharma Inc.
AGLE / Aeglea BioTherapeutics Inc
EL / The Estée Lauder Companies Inc.
OTIS / Otis Worldwide Corporation
BOLT / Bolt Biotherapeutics, Inc.
DHR / Danaher Corporation
GFL / GFL Environmental Inc.
HLT / Hilton Worldwide Holdings Inc.
MCK / McKesson Corporation
BHVN / Biohaven Ltd.
KURA / Kura Oncology, Inc.
FULC / Fulcrum Therapeutics, Inc.
RARE / Ultragenyx Pharmaceutical Inc.
STRO / Sutro Biopharma, Inc.
UNH / UnitedHealth Group Incorporated
MSFT / Microsoft Corporation
ITCI / Intra-Cellular Therapies, Inc.
MREO / Mereo BioPharma Group plc - Depositary Receipt (Common Stock)
ACLX / Arcellx, Inc.
INSM / Insmed Incorporated
COR / Cencora, Inc.
KALV / KalVista Pharmaceuticals, Inc.
MOLN / Molecular Partners AG - Depositary Receipt (Common Stock)
EYPT / EyePoint Pharmaceuticals, Inc.
IFRX / InflaRx N.V.
HUM / Humana Inc.